Jonathan D. Root, Director at Silverback Therapeutics, Inc. (SBTX), bought 2,364 shares at $52.07 ($36K) on 2021-03-03, disclosed to the SEC on 2022-03-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.07 | 350 | $18K | 50.6% |
| 2 | $8.85 | 2,014 | $18K | 49.4% |
| Total | $15.25 avg | 2,364 | $36K | 100% |
| Filing → |
| NARI | BUY | 2022-03-18 | $28K | — | Filing → |
| EFTR | SELL | 2021-12-06 | $46K | — | Filing → |
| EFTR | SELL | 2021-12-01 | $936K | — | Filing → |